MX2021007734A - Comprimido y metodo de preparacion del mismo. - Google Patents

Comprimido y metodo de preparacion del mismo.

Info

Publication number
MX2021007734A
MX2021007734A MX2021007734A MX2021007734A MX2021007734A MX 2021007734 A MX2021007734 A MX 2021007734A MX 2021007734 A MX2021007734 A MX 2021007734A MX 2021007734 A MX2021007734 A MX 2021007734A MX 2021007734 A MX2021007734 A MX 2021007734A
Authority
MX
Mexico
Prior art keywords
tablet
preparing same
tableting
fimasartan
economically
Prior art date
Application number
MX2021007734A
Other languages
English (en)
Spanish (es)
Inventor
Dong Chul Shin
Yunsam Kim
Myung Sic Kim
Yongyoun Hwang
Original Assignee
Boryung Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boryung Pharm filed Critical Boryung Pharm
Publication of MX2021007734A publication Critical patent/MX2021007734A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MX2021007734A 2018-12-31 2019-12-30 Comprimido y metodo de preparacion del mismo. MX2021007734A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180173649 2018-12-31
PCT/KR2019/018684 WO2020141825A1 (ko) 2018-12-31 2019-12-30 정제 및 이의 제조방법

Publications (1)

Publication Number Publication Date
MX2021007734A true MX2021007734A (es) 2021-08-05

Family

ID=71407061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021007734A MX2021007734A (es) 2018-12-31 2019-12-30 Comprimido y metodo de preparacion del mismo.

Country Status (7)

Country Link
KR (1) KR102465736B1 (zh)
CN (1) CN113260355A (zh)
MX (1) MX2021007734A (zh)
PH (1) PH12021551334A1 (zh)
SG (1) SG11202106025WA (zh)
WO (1) WO2020141825A1 (zh)
ZA (1) ZA202104403B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022260439A1 (ko) * 2021-06-09 2022-12-15 주식회사 보령 약학적 복합 제제 및 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101248804B1 (ko) * 2010-05-14 2013-03-29 한미사이언스 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제 및 이베살탄을 포함하는 이층정 약제학적 복합제제
KR20170061615A (ko) * 2015-11-26 2017-06-05 보령제약 주식회사 피마살탄의 신규 염
EP3184103A1 (en) * 2015-12-21 2017-06-28 Hexal AG Pharmaceutical composition comprising atorvastatin or a salt thereof

Also Published As

Publication number Publication date
CN113260355A (zh) 2021-08-13
KR20210100202A (ko) 2021-08-13
WO2020141825A1 (ko) 2020-07-09
SG11202106025WA (en) 2021-07-29
ZA202104403B (en) 2023-01-25
PH12021551334A1 (en) 2021-12-06
KR102465736B1 (ko) 2022-11-11

Similar Documents

Publication Publication Date Title
MX2016009440A (es) Polvo de titanio que contiene nitrógeno en solución sólida, material de titanio, y método para producir polvo de titanio que contiene nitrógeno en solución sólida.
TN2018000198A1 (en) Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
MX2020000369A (es) Metodos biologicos para preparar terpenos.
WO2018005201A8 (en) Quinolinyldiamido transition metal complexes, production and use thereof
MX2017008414A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
EP3504276A4 (en) LIGNIN PELLETS AND METHOD FOR THE PRODUCTION THEREOF
TN2017000435A1 (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
MX2015016797A (es) Masa para bebida soluble.
WO2020127145A3 (de) Materialien für elektronische vorrichtungen
MX2018000743A (es) Granulos de manitol para compresion directa.
EP3290968A4 (en) Display body, article, original plate, and method for producing original plate
EP3642741A4 (en) GEO-FENCING OF MEDIA CONTENT USING DISTRIBUTION AREAS IN A DATABASE
MY190747A (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
EP3290967A4 (en) Display body, article, original plate, and method for producing original plate
PH12015502832B1 (en) Processes for producing dark red and dark brown natural cocoa
MY183768A (en) Resin film and process for its production
MX2016009065A (es) Proceso para elaborar tabletas con el uso de radiofrecuencia y particulas disipativas revestidas.
PH12021551334A1 (en) Tablet and method of preparing same
WO2016161991A3 (zh) 一种硫酸氢氯吡格雷固体制剂及其制备方法
MX2017012079A (es) Material mixto resistente a balas.
PT3577070T (pt) Processo para produzir um briquete e briquete produzido de acordo com o mesmo
TWD180709S (zh) 控制筆
AU201717348S (en) Rack
MY188524A (en) Multistage polymer powder composition, its method of preparation and use
MY198300A (en) Mold release sheet for semiconductor compression molding and semiconductor package which is molded using same